dc.contributor.author | Abel zur Wiesch, Pia | |
dc.contributor.author | Clarelli, Fabrizio | |
dc.contributor.author | Cohen, Ted | |
dc.date.accessioned | 2018-03-21T11:10:43Z | |
dc.date.available | 2018-03-21T11:10:43Z | |
dc.date.issued | 2017-01-06 | |
dc.description.abstract | Identifying optimal dosing of antibiotics has proven challenging—some antibiotics are most effective when they are administered periodically at high doses, while others work best when minimizing concentration fluctuations. Mechanistic explanations for why antibiotics differ in their optimal dosing are lacking, limiting our ability to predict optimal therapy and leading to long and costly experiments. We use mathematical models that describe both bacterial growth and intracellular antibiotic-target binding to investigate the effects of fluctuating antibiotic concentrations on individual bacterial cells and bacterial populations. We show that physicochemical parameters, e.g. the rate of drug transmembrane diffusion and the antibiotic-target complex half-life are sufficient to explain which treatment strategy is most effective. If the drug-target complex dissociates rapidly, the antibiotic must be kept constantly at a concentration that prevents bacterial replication. If antibiotics cross bacterial cell envelopes slowly to reach their target, there is a delay in the onset of action that may be reduced by increasing initial antibiotic concentration. Finally, slow drug-target dissociation and slow diffusion out of cells act to prolong antibiotic effects, thereby allowing for less frequent dosing. Our model can be used as a tool in the rational design of treatment for bacterial infections. It is easily adaptable to other biological systems, e.g. HIV, malaria and cancer, where the effects of physiological fluctuations of drug concentration are also poorly understood. | en_US |
dc.description.sponsorship | Bill & Melinda Gates foundation
Swiss National Science Foundation
Northern Norway Regional Health Authority (Helse Nord)
UiT - The Arctic University of Norway | en_US |
dc.description | Source at <a href=https://doi.org/10.1371/journal.pcbi.1005321> https://doi.org/10.1371/journal.pcbi.1005321 </a>. | en_US |
dc.identifier.citation | Abel zur Wiesch, P., Clarelli, F. & Cohen, T. (2017). Using chemical reaction kinetics to predict optimal antibiotic treatment strategies. PloS Computational Biology, 13(1), 1-28. | en_US |
dc.identifier.cristinID | FRIDAID 1478679 | |
dc.identifier.doi | 10.1371/journal.pcbi.1005321 | |
dc.identifier.issn | 1553-734X | |
dc.identifier.issn | 1553-7358 | |
dc.identifier.uri | https://hdl.handle.net/10037/12399 | |
dc.language.iso | eng | en_US |
dc.publisher | Public Library of Science | en_US |
dc.relation.journal | PloS Computational Biology | |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Biofarmasi: 736 | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Biopharmacy: 736 | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical molecular biology: 711 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk molekylærbiologi: 711 | en_US |
dc.title | Using chemical reaction kinetics to predict optimal antibiotic treatment strategies | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |